PATENT CLAIM ANALYSIS

Application Number: 16306361
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["424", "401000"]

Abstract:
There is provided a skin care formulation for transdermal administration of a component of a blood product, the formulation comprising a blood product, a transdermal carrier; and a liposomal base, wherein at least a portion of the blood product and transdermal carrier is contained within liposomes of the liposomal base.

Claim (Index 9):
The formulation of  claim 7  wherein the cytokine is selected from the group consisting of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-1\u03b1, IL-1\u03b2, IL-2, IL-2R, IL-3, IL-6, IL-7, IL-8, IL-9, IL-10, IL-11, IL-12, IL-12, p40/p70, IL-13, IL-14, IL-15, IL-17, tumour necrosis factor (TNF)\u03b1, TNF-\u03b2, interferon (IFN)-\u03b1, INF-\u03b2, INF-\u03b3, IL-1RA, IL-4, IL-5, IL-10, IL-13, IFN\u03b1, and any combination thereof.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 98.0
- Lexical Diversity: 1.83333
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13945120', '13041197', '14911215', '14132549', '15147715']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7631494906818791
- 35 USC 102 Novelty (BERT): 0.5001853740456477
- Combined Prediction Score: 0.7368530790182559
- Mean Citation Score: 205.539946
- Max Citation Score: 224.02826
- Similarity Product: 144.47827385846375

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test